Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,357.20
(
0.00%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.53
(
0.05%
)
Bitcoin
76,776.98
(
-0.82%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 10/18/2007 1:31:03 AM

Thursday, October 18, 2007 1:31:03 AM

Post# of 3757
Thomas Ebeling, one of two NVS directors on IDIX’s BoD, has switched jobs from head of NVS’ pharma business to head of the consumer-health business. I think it’s fair to say he was demoted. (Source: NVS’ 3Q07 PR, which was issued minutes ago.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote